These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 16078405)

  • 41. Public biotech 2007--the numbers.
    Lawrence S; Lähteenmäki R
    Nat Biotechnol; 2008 Jul; 26(7):753-62. PubMed ID: 18612294
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Consensus document on European brain research.
    Olesen J; Baker MG; Freund T; di Luca M; Mendlewicz J; Ragan I; Westphal M
    J Neurol Neurosurg Psychiatry; 2006 Aug; 77 Suppl 1(Suppl 1):i1-49. PubMed ID: 16845120
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Financial capital and intellectual capital in physician practice management.
    Robinson JC
    Health Aff (Millwood); 1998; 17(4):53-74. PubMed ID: 9691550
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Just how good an investment is the biopharmaceutical sector?
    Thakor RT; Anaya N; Zhang Y; Vilanilam C; Siah KW; Wong CH; Lo AW
    Nat Biotechnol; 2017 Dec; 35(12):1149-1157. PubMed ID: 29220034
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Investing in acute health services: is it time to change the paradigm?
    Kerr R; Hendrie DV; Moorin R
    Aust Health Rev; 2014 Nov; 38(5):533-40. PubMed ID: 25164470
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A blueprint for biotech's blues.
    Nat Biotechnol; 2009 Aug; 27(8):675. PubMed ID: 19668152
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Involving citizens and patients in health research.
    Venuta R; Graham ID
    J Ambul Care Manage; 2010; 33(3):215-22. PubMed ID: 20539148
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Share slump brings biotech firms to government's door.
    Check E
    Nature; 2003 Jun; 423(6943):908. PubMed ID: 12827159
    [No Abstract]   [Full Text] [Related]  

  • 49. Brief of the Canadian Society for Clinical Investigation to the science and technology review.
    Clin Invest Med; 1995 Feb; 18(1):80-90. PubMed ID: 7768069
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Public biotech 2013--the numbers.
    Lawrence S; Lahteenmaki R
    Nat Biotechnol; 2014 Jul; 32(7):626-32. PubMed ID: 25004227
    [No Abstract]   [Full Text] [Related]  

  • 51. Intellectual property conundrum for the biological sciences.
    Olds JL
    Anat Rec B New Anat; 2004 Mar; 277(1):5-9. PubMed ID: 15052648
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Moving research to patient applications through commercialization: understanding and evaluating the role of intellectual property.
    Patino RM
    J Am Assoc Lab Anim Sci; 2010 Mar; 49(2):147-54. PubMed ID: 20353687
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential effects of public and private funding in the medical device industry.
    Kang HD; Edelman ER; Ku DN
    Expert Rev Med Devices; 2018 Feb; 15(2):91-98. PubMed ID: 29256320
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Members' of Parliament knowledge of and attitudes toward health research and funding.
    Clark DR; McGrath PJ; MacDonald N
    CMAJ; 2007 Oct; 177(9):1045-51. PubMed ID: 17954894
    [TBL] [Abstract][Full Text] [Related]  

  • 55. How does venture capital operate in medical innovation?
    Lehoux P; Miller FA; Daudelin G
    BMJ Innov; 2016 Jul; 2(3):111-117. PubMed ID: 27547447
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The price of progress: Funding and financing Alzheimer's disease drug development.
    Cummings J; Reiber C; Kumar P
    Alzheimers Dement (N Y); 2018; 4():330-343. PubMed ID: 30175227
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Wasting cash--the decline of the British biotech sector.
    Smith G; Akram MS; Redpath K; Bains W
    Nat Biotechnol; 2009 Jun; 27(6):531-7. PubMed ID: 19513054
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role and reality: technology transfer at Canadian universities.
    Bubela TM; Caulfield T
    Trends Biotechnol; 2010 Sep; 28(9):447-51. PubMed ID: 20598388
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Physician entrepreneur: lessons learned in raising capital for biomedical innovation.
    Soleimani F; Kharabi DG
    Curr Opin Anaesthesiol; 2010 Apr; 23(2):209-17. PubMed ID: 20173634
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Development of biotechnology in India.
    Ghose TK; Bisaria VS
    Adv Biochem Eng Biotechnol; 2000; 69():87-124. PubMed ID: 11036692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.